Patient Recruitment and Enrollment in Clinical Trials

Recruiting participants for clinical trials can be a bigger challenge than conducting the trials themselves. A delay in recruitment stretches the study's timeline, pushing back the treatment's market availability. Take a look at the infographic below to grasp how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.

Patient Recruitment and Enrollment Infographic

Discovering Clinical Trials

Seventy-two percent of participants are existing patients, while 28% are new.
Top sources of clinical trial information:
Fifty-eight percent from primary care physicians
Forty percent from online registries
30% from search engines
Nineteen percent from primary care nurses
Nineteen percent from pharmaceutical companies
Motivations for Participation

Top perceived benefits:
26% to advance medicine
36% to improve others' lives
Fifteen percent to improve their condition
Eight percent as the best treatment here option
5% for monetary compensation
Factors influencing participation:
60% physical location
Sixty-three percent confidentiality
73% types of procedures
75% study purpose
83% potential risks and benefits
Enrollment Challenges

Thirty-seven percent of sites under-enroll, with eleven percent failing to enroll any patients.
Doubling original timelines helps 90% of trials meet enrollment goals.
70% of the public haven't considered clinical trials, with nineteen percent unwilling to participate and seven percent unsure.
Top perceived risks:
40% side effects
33% overall health risks
7% receiving placebo
Seven percent stopping beneficial treatments
Forty percent lack confidence in finding a suitable study, and seventy percent seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: 74% are open to discussing trial participation in online peer communities, and 94% of volunteers would participate again.

To learn more visit our website at

Patient Recruitment and Enrollment in Clinical Trials

Leave a Reply

Your email address will not be published. Required fields are marked *